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Summary 
Radioresistant host elements mediate positive selection of developing thymocytes, whereas bone 
marrow-derived cells induce clonal deletion of T cells with receptors that are strongly autoreactive. 
In contrast  to T  cell development, little is known about the elements governing the natural 
killer (NK) cell repertoire, which, similar to the T  cell repertoire, differs between individuals 
bearing different major histocompatibility complex (MHC) phenotypes. We have used routine 
bone marrow transplantation models to analyze the influence of donor and host MHC on an 
NK cell subset. We examined the expression of Ly-49, which is strongly expressed on a subpopulation 
of NK cells of H-2 b mice, but not by NK cells of H-2 a mice, probably because of a negative 
effect induced by the interaction of Ly-49 with D a. To evaluate the effect of hematopoietic cell 
H-2 ~ expression on Ly-49 expression of H-2  b NK cells, we prepared mixed allogeneic chimeras 
by administering T  cell-depleted allogeneic (B10.A,  H-2 ~) and host-type (B10, H-2 b) marrow 
to lethally irradiated B10 mice, or by administering B10.A marrow to B10 recipients conditioned 
by a nonmyeloablative regimen. Expression of H-2 ~ on bone marrow-derived cells was sufficient 
to downregulate Ly-49 expression on both H-2 ~ and H-2 b NK cells. This downregulation was 
thymus  independent.  To  examine  the  effect  of H-2 ~ expressed  only  on  radioresistant  host 
elements, we prepared fully allogeneic chimeras by administering B10 bone marrow to lethally 
irradiated  B10.A  recipients.  B10  NK  cells  of these  fully  allogeneic  chimeras  also  showed 
downregulation of Ly-49 expression. The lower level of H-2 ~ expressed on H-2 b x  H-2 ' F1 cells 
induced more marked downregulation of Ly-49 expression on B10 NK cells when presented 
on donor marrow in mixed chimeras than when expressed only on radioresistant host cells. Our 
studies show that differentiation of NK cells is determined by interactions with MHC molecules 
expressed on bone marrow-derived cells and,  to a lesser extent, by MHC  antigens expressed 
on radioresistant host elements. 
T  cells undergo negative and positive selection during de- 
velopment, resulting in self-MHC-restricted recognition 
ofpeptide antigens, and deletion ofT cell clones with strong 
reactivity to self-antigens. Positive selection is thought to be 
mediated predominantly by thymic epithelial cells, whereas 
clonal deletion of self-reactive T cell progenitors is mediated 
primarily by bone marrow-derived cells populating the thymus 
(1, 2). Less is known about the selection processes which NK 
cells undergo during their differentiation. Although patterns 
of NK cell-mediated recognition are known to differ between 
MHC-disparate mouse strains (3) and human individuals (4), 
the environmental determinants of the NK cell repertoire have 
yet  to  be defined.  We  have  used radiation  bone  marrow 
chimeras to address separately the influence of bone marrow- 
derived cells and of radioresistant host elements on NK cell 
expression of a surface molecule that recognizes MHC class 
I  antigens and regulates cytolytic activity. 
Ly-49 is a recently defined surface molecule expressed on 
a subpopulation of NK cells (5). The putative interaction of 
Ly-49 with D d or D k class I MHC molecules on target cells 
globally inhibits cytolysis by Ly-49 +  NK  cells suggesting 
that Ly-49 is an inhibitory NK cell receptor specific for these 
MHC class I antigens (5). Presumably resulting from a negative 
effect induced by recognition of D a or D k, Ly-49 is not de- 
tected on NK cells of animals bearing these MHC antigens 
(6).  We took advantage of this observation to evaluate the 
effect of D a expression on bone marrow  or radioresistant 
host elements on NK cell Ly-49 expression. 
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Animals.  C57BL/10  (B10, H-2  s,  KblbDS), B10.A (H-2  ~, 
KklkDa), A/JScNCR (A/J, H-2') and (B10 x  B10.A)F, (H-2  b x 
H-2  ~) mice were purchased from Frederick Cancer Research Fa- 
cility, (Frederick, MD). B10.BR (H-2  k, KtIkD  k) mice were pur- 
chased from the Jackson Laboratory (Bar Harbor, ME). Mice were 
housed in sterile microisolator cages in a viral antibody-free envi- 
ronment. 
Bone Marrow Transplantation (BMTy.  Chimeras  were prepared 
as described (7) by reconstituting 10.25 Gy whole body irradiated 
(WBI)  (1.03 Gy/min,  137Cs source) B10, B10.A, or  (B10  x 
B10.A)F1 mice, or 9.5 Gy WBI A/J mice with the indicated T 
cell-depleted (TCD)  marrow inocula. T  cell depletion of bone 
marrow cells (BMC) was carried out as described (8). All bone 
marrow inocula were T cell depleted, unless otherwise indicated. 
Another BMT model involved administration of 5 x  10  ~ non- 
TCD B10 BMC to B10.BR mice conditioned with sublethal (7 
Gy) total body irradiation (TBI) and pretreated  with depleting doses 
of anti-NKl.1  mAb PK136 (9) on days -6 and  -1 before BMT. 
These animals showed complete donor-type reconstitution in the 
lymphoid and myeloid lineages. 
A third BMT model involved  administration of 15  x  106 non- 
TCD B10.A or A/J BMC to B10 mice pretreated with anti-CD4 
and anti-CD8 mAbs, 7 Gy thymic irradiation, and 3 Gy TBI. This 
nonmyeloablative conditioning regimen led to induction of per- 
manent mixed chimerism after BMT, as previously  described (10). 
Thymectomy.  Animals  were anaesthetized  intraperitoneally  with 
pentobarbital and thymectomized by en bloc excision  after a partial 
median sternotomy, as described (11). 
mAbs and Flow Cytometry (FCM).  FCM analyses  were  performed 
|  |  on a FACScan  or FACSort  (Becton  Dickinson & Co., Mountain 
View, CA). Chimerism was evaluated  by FCM analysis  of periph- 
eral white blood cells (WBC) prepared by hypotonic lysis  of RBC. 
WBC were stained with FITC- or biotin-conjugated (plus PE- 
streptavidin [PEA]) De-specific mouse IgG2a mAb 34-2-12 (12), 
Kk-specific mouse IgG2a mAb 16-1-11 (13), or Kk-specific  mouse 
IgG2a mAb  36-7-5 (13) to distinguish  H-2" (De-positive, K  k- 
positive) cells from H-2  b (De-negative, Kk-negative)  cells. Nonreac- 
tive IgG2a mAb HOPC1 was used as a negative  control Chimerism 
was evaluated  for lymphocytes,  monocytes,  and granulocytes,  which 
could be distinguished on the basis of forward angle versus 90  ~ 
light scatter characteristics. 
For analysis of Ly-49 expression on NK cells, PBL were pre- 
pared and labeled with anti-Ly-49  mAb A1-FITC (14) and NKI.1- 
specific IgG2a mAb PKD6-biotin (PharMingen, San Diego, CA) 
plus PEA, or with PK136-PE (PharMingen). To determine the per- 
centage of NKI.1 + cells that were Ly-49  +, 10,000 gated PK136  + 
cells (distinguished  by staining  above  negative  control mAb HOPC1- 
biotin/PEA or Leu4-PE) were collected  for analysis  of  staining with 
A1-FITC. The percentage of gated PK136  + cells staining with 
control antibody HOPC-1-FITC was subtracted  from the percentage 
of gated PKD6 + cells staining with A1-FITC. PBL were also 
stained with negative control mouse IgG2a mAb HOPC1-FITC 
versus  PK136-biotin/PEA  and  36-7-5 (anti-Kk)-FITC versus 
PK136-biotin/PEA (or PK136-PE). 
1 Abbreviations used in this paper: BMC, bone marrow cell; BMT, bone 
marrow transplantation; Cy-SA, CyChrome-streptavidin;  FCM, flow 
cytometry;  PEA, phycoerythrin-streptavidin;  TBI, total  body  irradiation; 
TCD, T call depleted. 
For three-color FCM analysis,  PBL were stained with combina- 
tions  of a FITC-,  a PE-, and  a biotin-conjugated mAb  with 
CyChrome-streptavidin (Cy-SA; PharMingen). FITC-conjugated 
mAbs were HOPC-1 (control) and A1; PE-conjugated mAbs were 
anti-human CD3 mAb Leu4 (negative control; Becton Dickinson 
& Co.) and PKD6; biotin-conjugated antibodies  were hamster IgG 
(Hamlg control), anti-TCR-c,/fl mAb H57-597 (15) (Pharmingen), 
HOPC-1  (control), and anti-D e mAb 34-2-12. To determine the 
percentage of Ly-49  + NK cells that expressed TCR.-cx/fl,  10,000 
gated PK136  + cells were collected. The percentage of Ly-49  § 
PKD6 + cells staining  with Hamlg-bio/Cy-SA was  subtracted 
from the percentage of Ly-49  + PK136  + cells staining with H57- 
597-bio/Cy-SA. To analyze Ly-49 expression on B10 NK cells in 
PBL of chimeras, 10,000 gated NKI.1 + cells were collected, and 
D  e-, NKI.1 + cells were selected on FL2  x  FL3 plots for com- 
parison of  green fluorescence  staining with A1-FITC  to background 
staining with HOPC1-FITC. 
Results and Discussion 
Recovery of Ly-49 + NK Ceils in Syngeneic (BIO--~BIO) BMT 
Recipients.  We used two-color FCM with Ly-49-specific 
mAb A1  to evaluate Ly-49 expression on NKI.1 § ceUs of 
chimeras prepared  in  the B10.A  (H-2',  Da+)/B10  (H-2  b, 
D d-) strain combination. At all time points tested 7-30 wk 
after BMT, B10-*B10  BMT recipients showed similar per- 
centages of Ly-49 + NK ceils to those in B10 controls tested 
in the same assay (Figs.  If and 2). Although "duU" Ly-49 
staining was variably detected on NK cells of De-bearing 
H-2'  B10.A,  H-2  b  x  H-2'  (B10  x  B10.A)F1,  or  H-2  k 
B10.BR mice (e.g., Ly-49 staining producing a dull "shoulder" 
above background staining on B10.A NK cells had a peak 
fluorescence of 10 channds, compared with 41 channels for 
the distinct peak produced by Ly-49 staining of B10 NK ceils 
in the same assay), brightly staining Ly-49 + cells were not 
detected on normal mice of these strains,  consistent with 
previous results (6). The reason for this variable dull Ly-49 
expression is not known, and is currently under investigation. 
A  subpopulation of NKI.1 + cells  expresses  TCR-ol//3 
(16-18). We used three-color FCM analysis to determine the 
percentage of NKI.1 +, Ly-49 + ceils that expressed  TCR- 
o~/3 in PBL of three B10-~B10 BMT recipients and a normal 
B10 mouse. Only 1.22-6.01%  of NKI.1 + Ly-49 + PBL ex- 
pressed TCK-c~/3. Thus, the vast majority of NKI.1 + Ly- 
49 + cells were TCP,-oJB-negative. 
1-1-2  a Bone Marrow Downregulates Ly-49 Expression on 1-1-2  ~ 
NK  Ceils.  To examine the effect of hematopoietic cell H-2  a 
(D  d§  expression  on Ly-49 expression  by D a-  NK cells, we 
prepared mixed chimeras by reconstituting lethally irradiated 
B10 mice with a mixture of TCD allogeneic and syngeneic 
(host type) marrow obtained from B10 and B10.A donors 
(i.e., B10+ B10.A-*B10).  These mixed chimeras show specific 
T call tolerance to antigens of the donor and of the host (19). 
The percentage of NKI.1 + ceUs in PBL of control and chi- 
meric animals was similar (3.4  _+  1.3% SD for normals; 2.8 
_+  1% SD for mixed chimeras; P  =  0.1), and two-color FCM 
analysis showed that the proportion of NK cells of donor 
and host type was similar to the proportion of total PBL of 
each type. For example, in a chimera in which 48.5 % of PBL 
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Figure  1.  Ly-49  downregulation on NK cells of mixed 
chimeras.  K  k (a-d)  and Ly-49 (e-h)  staining is shown for 
gated NKI.1 + PBL from normal B10.A (a and e), B10-~B10 
BMT recipient (b and  J), B10+B10.A-~B10.A (c andg), and 
B10+B10.A~B10 mixed chimera (d and h) 8 wk after BMT. 
Despite  the presence of K k- (B10) NK cells in both types 
of mixed chimeras (c and d), significant Ly-49 expression was 
not detectable (g and h). 
were D a positive (i.e.,  of B10.A origin), 44.2% of NKI.1 + 
cells were D a positive; in a chimera in which 80% of PBL 
were D a positive, 81.2% of NKI.1 + cells were D a positive. 
NK cells from B10+B10.A-~B10 chimeras analyzed 7-29 
wk after BMT did not express Ly-49 above levels seen in B10.A 
controls. Similar results were observed in B10 + B10.A-~B10.A 
chimeras (Fig.  1, g  and h,  respectively, and Fig.  2). Fig.  1, 
c and d show the presence of B10.A (K  k+) and orB10 (K  ~-) 
NK cells in PBL of both animals presented in Fig. 1, g and h. 
Heterozygous expression of H-2  ~ on (B10  x  B10.A)Ft 
donors also markedly reduced Ly-49 expression on B10 NK 
cells in mixed chimeras prepared in B10 recipients (Figs.  2 
and 3). Similar results were obtained in spleens and PBL from 
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Figure  2.  H-2~  expressed on bone marrow-derived  cells or on radio- 
resistant host elements downregnlates Ly-49 expression on B10 NK cells. 
The mean percentage  +  SD of NKI.1 + PBL expressing Ly-49 at 5-9 wk 
after BMT is shown for lethally irradiated  (10.25 Gy) B10, B10.A and 
(B10  x  B10.A)F, recipients of the indicated TCD BMC inocula. One 
group of B10.A mice received non-TCD B10 marrow, as indicated.  (*) 
Significant difference from B10-+B10 syngeneic controls (p < 0.05, Stu- 
dent's t test).  The mean  _+  SD percentage of NKI.1 + PBL expressing 
Ly-49 was 8.3  _+ 3.8 for normal B10 (n  =  15), 0.5  _+ 0.5 (n =  10) for 
normal B10.A, and 0.55 (n  =  2) for normal (B10 x  B10.A)F1 controls. 
Mean percentages of Dd-positive PBL in mixed chimeras were as follows 
(TCD BMC donors, left of the arrow; recipient strains, fight of the arrow): 
B10+B10.A-~B10 68.6% (range 28.2-90.7%); B10+ B10.A-~B10.A  45.7% 
(range  22.7-90.0%);  B10+(B10  x  B10.A)F1--*B10 68.7%  (range 
64.4-72.0%). 
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lethally irradiated  B10 mice reconstituted  with  TCD  A/J 
(H-2L D a+) plus TCD B10 BMC analyzed 15-29 wk after 
BMT (data not shown). The marked reduction in Ly-49 ex- 
pression  on  NK cells  of mixed chimeras  prepared  in B10 
recipients shows that the presence of H-2' bone marrow-de- 
rived cells is sui~cient to downregulate Ly-49 expression on 
both H-2  b and H-2  '  NK cells. 
In another model, tolerant mixed allogeneic chimeras pre- 
pared by administering B10.A or A/J BMC to B10 recipients 
conditioned by a nonmyeloablative regimen involving 3 Gy 
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Figure 3.  (B10 x  B10.A)Ft bone marrow-derived cells downregulate 
Ly-49 expression on B10 NK cells to a greater extent than do radioresis- 
rant (B10 x  B10.A)F1  host cells. (Solid hbtograms) Staining with nonreac- 
tive control mAb HOPC-1-FITC; (empty histograms) staining with anti- 
Ly-49 mAb A1-FITC on gated D d-, NKI.1 + PBL obtained from typical 
B10-~B10, B10+(B10  x  B10.A)Ft-+B10, and BIO-+(B10 x  B10.A)Ft 
BMT recipients analyzed by three-color FCM in a single assay performed 
10-23 wk after BMT. Gated D d+ NKI.1 + PBL were analyzed for (B10 
x  B10.A) Ft ~  (B10 x  B10.A) Ft recipients (top right) in the same assay. TBI,  7 Gy thymic irradiation,  and administration  of anti- 
CD4 plus anti-CD8 mAbs as previously described (10), showed 
a similar downregulation  of Ly-49 expression on B10 NK 
cells 3 and 20 wk after BMT (data not shown). Therefore, 
engraftment  of H-2 '  BMC without  lethal  irradiation  was 
sufficient to downregulate Ly-49 expression on B10 NK cells 
as early as 3 wk after BMT. 
Similar downregulation of Ly-49 expression was also ob- 
served in chimeras prepared by this regimen after adult thymec- 
tomy (data not  shown),  indicating  that  bone marrow-de- 
rived cells can exert their downregulatory influence on Ly-49 
expression at  an extrathymic  site. 
A  previous study showed that  administration  of B2 mi- 
croglobulin-negative,  class I MHC-deficient bone marrow 
to class I-expressing recipients results in a pattern of NK cell 
function that resembles that  of the class I-deficient donors 
(20). Our Ly-49 studies in mixed chimeras demonstrate for 
the  first  time  that  MHC  molecules  expressed  on  bone 
marrow-derived cells can influence the differentiation of NK 
cells not expressing these MHC molecules. This result sug- 
gests that expression of alloantigen  on donor bone marrow--de- 
rived cells might tolerize host-type NK cells that could other- 
wise  be  alloreactive  against  donor  marrow.  Since  mixed 
chimerism confers several advantages over completely allogeneic 
reconstitution  as an approach to tolerance induction across 
both allogeneic and xenogeneic barriers (19, 21), the possible 
ability of donor marrow-derived cells to tolerize host-derived 
NK cells could have important implications, particularly in 
xenotransplantation, in which NK cells present an even greater 
barrier  than  they do for allogeneic BMT  (10,  21). 
Expression  of H-2  ~ on Radioresistant Host Elements  Down- 
regulates Ly-49 Expression  on BIO NK  Cells.  To determine 
whether D d expression on radioresistant  host elements could 
also downregulate Ly-49 expression, we studied fully allogeneic 
TCD B10--*B10.A  (10.25 Gy WBI) chimeras, in which D d 
is expressed only by the host.  In these chimeras,  Ly-49 ex- 
pression was markedly downregulated on B10 NK cells evalu- 
ated 4-39 wk after BMT (Figs.  4 f and 2). 
A small proportion of host-type cells is detectable in the 
PBL of allogeneic chimeras of this type (22) (Fig.  4 d).  To 
rule out the possibility that these residual host-type cells are 
required  for Ly-49 downregulation,  we performed  similar 
studies in B10.A recipients of non-TCD B10 marrow, in which 
no host-type lymphohematopoietic cells are detectable (22) 
(compare Fig. 4 g to syngeneic B10--*B10 control, Fig. 4 a). 
These animals also showed marked downregulation of Ly-49 
expression on B10 NKI.1 + cells (e.g., Figs.  4 i and 2), indi- 
cating that detectable H-2' bone marrow-derived cells need 
not be present  in order to induce Ly-49 downregulation. 
A  similar  analysis  was  performed  on  fully  aUogeneic 
B10--~B10.BR chimeras prepared by administration  of 5  x 
i0  6 non-TCD BIO BMC to 7 Gy irradiated,  NK cell--depleted 
B10.BR (H-2  k) mice.  H-2  k mice normally do not contain 
brightly staining Ly-49 + NK cells  (6).  Only  1.0  _+  0.7% 
of B10 NK cells from B10-'*B10.BR recipients expressed Ly- 
49 10 wk after BMT. However, unlike results in B10.A hosts, 
NK cells from B10--*B10.BR chimeras showed an eventual 
increase in Ly-49 expression, with NK cells of three of four 
animals analyzed 30 wk after BMT showing percentages and 
intensities  of Ly-49 expression that were below those detected 
in B10--~B10 BMT recipients, but significantly greater than 
those detected in normal B10.BR controls.  The fourth an- 
imal resembled a normal B10.BR control.  Thus,  the dura- 
tion of Ly-49 downregulation induced by an H-2  a host en- 
vironment  was  more prolonged  than  that  induced  by an 
H-2  k host environment with similar background genes,  sug- 
gesting differences in the potency of different MHC mole- 
cules  in  mediating  this  effect.  Studies  performed  in  the 
B10-*A/J (H-2b~H-2  ') strain combination, however, showed 
only a partial  reduction in the percentage of NK cells  ex- 
pressing Ly-49 and in the intensity of Ly-49 expression on 
B10 NK cells (data not shown), suggesting that host factors 
in addition to MHC may influence Ly-49 expression. Studies 
are in progress to identify these additional host influences. 
To determine whether the level of H-2' expressed on host 
tissues was critical in determining Ly-49 expression on B10 
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Figure 4.  Expression  of H-2  ￿9 on radioresistant host ele- 
ments leads to downregulated Ly-49 expression on NKI.1  + 
cells. (a, d, and g) K  k expression on PBL of B10(-T) (i.e., 
TCD B10)--*B10,  B10(-T)--*B10.A, and B10(+T) (i.e., non- 
TCD B10)---~B10.A  BMT recipients, respectively. A small 
population of surviving K  k+ B10.A cells can be detected in 
PBL from B10.A recipients of TCD B10, but not of non- 
TCD B10 marrow (d vs g). (b, e, and h) Control staining 
with FITC-HOPC1 mAb for gated NKI.1 § cells of these 
BMT recipients. (c, f, and i) Staining of the same gated 
NKI.1 § populations with anti-Ly-49 mAb A1-HTC. 
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(B10  x  B10.A)F1 recipients of TCD B10 BMC. Although 
the percentage of Ly-49 + NK cells and the intensity of Ly- 
49 staining in these mice was significantly reduced compared 
with syngeneic controls (percentages summarized in Fig. 2; 
typical FCM histograms shown in Fig. 3), this reduction was 
much less marked than that observed for B10 NK cells de- 
veloping in homozygous B10.A recipients, or for B10 NK 
cells in B10+(B10  x  B10.A)FI-*B10 BMT recipients (Figs. 
2 and 3).  These results suggest that a higher level of H-2  ~ 
expression is required on the radioresistant host environment 
than on bone marrow-derived cells in order to produce a 
similar degree of Ly-49 downregulation on H-2  b NK cells. 
Thus,  the  MHC  phenotype  of the  host  environment 
influences NK cell Ly-49 expression, but to a lesser degree 
than does the MHC of engrafted bone marrow. Preliminary 
results of functional studies using the RMA tumor in chimeras 
are consistent with those presented here i.e., an influence of 
bone  marrow-derived cells  and  of the  host  nonlympho- 
hematopoietic environment on NK cell function can be de- 
tected (our unpublished data). Radioresistant host elements 
that  might influence NK cell development could include 
marrow stroma, since the normal marrow environment ap- 
pears to play an important role in NK cell development (23). 
Although our FCM technique was sensitive to 0.1%  con- 
tamination of H-2-disparate cells in a mixing study, and adop- 
tive transfer studies from fully allogeneic chimeras in class 
I-mismatched donor-host combinations suggest that no host- 
type hematopoietic stem cells survive after lethal irradiation 
and non-TCD allogeneic BMT (our unpublished data), we 
have not ruled out the formal possibility that host marrow-de- 
rived cells below the level of detection in these assays survive 
in non-TCD B10-~B10.A chimeras. However, we believe it 
is unlikely that such low levels of microchimerism within 
the lymphohematopoietic system, if present, would mediate 
the  potent  and  durable  effect we  observed in  non-TCD 
B10-*B10.A chimeras. It is also formally possible that long- 
lived radioresistant host marrow- derived cells residing outside 
of the lymphohematopoietic system, such as host Langerhans 
cells that persist in the skin of long-term chimeras (our un- 
published  data),  are the radioresistant  host  elements that 
influence the NK cell repertoire. 
Previous studies suggested that the interaction of Ly-49 
on NK cells with D a expressed on target cells provides a 
negative signal to the NK cell, resulting in failure to kill the 
target (5). The reduced Ly-49 expression on NK cells of D a- 
bearing mice, and of chimeras expressing D a on bone mar- 
row-derived cells or radioresistant host elements, is consis- 
tent with the hypothesis that negative signaling through this 
interaction with D a in vivo leads to either destruction of Ly- 
49 + NK cells or to downregulation of Ly-49 expression.  We 
favor the possibility that Ly-49 expression is downregulated, 
as we have seen a continuum in the level of Ly-49 expression, 
with reduced anti-Ly-49 staining intensity in B10-~(B10  x 
B10.A)F1 (Fig. 3), B10-*A/J, and long-term B10--*B10.BR 
chimeras. Even lower, but nevertheless detectable, levels of 
Ly-49 expression were variably detected on normal B10.A, 
(B10  x  B10.A)F1  and  B10.BR  NK  cells,  and  in  mixed 
chimeras involving H-2  a donors. Thus, it is possible that all 
of the differences between strains and various types of  chimeras 
reflect varying intensities of Ly-49 expression, rather than the 
presence or absence of Ly-49 + NK cells. 
Ly-49 is one of a family of structurally similar type II inte- 
gral membrane proteins that is genetically linked to the NKR- 
P1 family of NK cell-associated genes on mouse chromo- 
some 6 (14, 24, 25). If the interaction of such an NK-associated 
structure, or a combination of such structures on a single 
NK cell, results in a high affinity interaction with the target 
cell's class I MHC molecules, then perhaps the negative signal 
transduced to the NK cell could lead to downregulation of 
the interacting surface molecule(s) or deletion of that NK 
cell subset. The lack of Ly-49 expression on NK cells of D a+ 
mice or chimeras might reflect a very high affinity interac- 
tion between D a and Ly-49, resulting in such a potent nega- 
tive signal that high levels of Ly-49 expression do not persist. 
If, on the other hand, the overall affinity of these interactions 
were  intermediate,  then  the  less  intense  negative  signal 
provided by interactions with self-dass I  MHC molecules 
might prevent the killing of autologous targets while allowing 
that NK cell subset to persist in vivo.  These NK cells,  on 
the other hand, would kill targets not expressing the rele- 
vant self-class I molecule(s), leading to a pattern of lysis con- 
sistent with the "missing self" hypothesis (26-28). 
Another NK cell subset marker, recognized by mAb 5E6, 
is expressed on NK cells that resist engraftment of homozy- 
gnus H-2  a but not of H-2  b marrow (29).  Thus, interactions 
of the 5E6 molecule with MHC molecules could be postu- 
lated. Ly-49 expression is dowuregulated in mice expressing 
the MHC molecules to which it presumably can bind, whereas 
5E6 + NK cells are detectable in animals expressing D a. This 
difference could be explained by our affinity/NK cell subset 
model. Since 5E6 + NK cells cannot reject H-2  b marrow, it 
could be postulated that the 5E6 molecule is an Ly-49-1ike 
recognition structure with intermediate affinity for D b. Ex- 
pression of 5E6 would ensure that this subset of NK cells 
did not kill autologous targets in H-2  b  x  H-2  d mice, and 
would not reject homozygous H-2  b marrow.  In contrast, 
5E6-  NK cells in F1 mice might rely on expression of an 
H-2a-binding Ly-49-1ike molecule to inhibit lysis of autol- 
ogous targets, and would thus be unable to reject homozy- 
gous H-2  a marrow. The 5E6 + subset present in H-2  a homo- 
zygous mice, on the other hand, might express an additional 
Ly-49-1ike molecule that interacts with intermediate affinity 
to an H-2  a MHC molecule in order to prevent killing of its 
autologous, Db-negative cells. Thus, phenotypically distin- 
guishable subsets of 5E6 + cells might be present in homozy- 
gnus versus heterozygous H-2  a versus H-2  m'b F1 mice. Coex- 
pression of a combination of clonally distributed NK cell 
surface molecules has recently been reported to be associated 
with the inability of human NK cells to kill targets bearing 
HLA-Cw3  (4,  30). 
Our in vivo studies indicate that NK cell phenotype is most 
readily controlled by MHC expressed on bone marrow-de- 
rived cells, but can also be regulated by radioresistant host 
227  Sykes  et al. cells.  Thus,  NK cells  resemble T  cells  in that both bone 
marrow-derived and radioresistant host elements determine 
the presence or absence of cells with certain MHC recogni- 
tion structures, although bone marrow-derived cells have a 
more potent ability to ensure that mature cells with host- 
reactive receptors are not released (31, 32). This negative se- 
lection of  T cells is mediated by a process of  cell death, whereas 
it remains possible that negative selection of Ly-49-bearing 
NK cells is not due to permanent deletion but to dynamic 
regulation of Ly-49 expression by another mechanism, such 
as decreased transcription, translation or post-translational 
processing. Studies currently in progress should help to fur- 
ther darify the mechanism and site of NK cell adaptive differen- 
tiation. 
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